Skip to main content
ArticleOPEN ACCESS

Playing with fire

Ophthalmic Surgery Lasers and Imaging Retina
DOI: 10.3928/23258160-20201005-01
1Citations
Citations of this article
217Readers
Mendeley users who have this article in their library.

Abstract

The authors present their concerns surrounding data presented in studies from 2018 and 2020 regarding very low dose bevacizumab for the treatment of retinopathy of prematurity.

References Powered by Scopus

Reactivation of retinopathy of prematurity after ranibizumab treatment

Retina
118Citations
N/AReaders
Get full text

Follow-up to Age 4 Years of Treatment of Type 1 Retinopathy of Prematurity Intravitreal Bevacizumab Injection versus Laser: Fluorescein Angiographic Findings

Ophthalmology
95Citations
N/AReaders
Get full text

A Dosing Study of Bevacizumab for Retinopathy of Prematurity: Late Recurrences and Additional Treatments

Ophthalmology
89Citations
N/AReaders
Get full text
View more at Scopus

Cited by Powered by Scopus

Low-Dose Bevacizumab - But What about Long-term Results?

JAMA Ophthalmology
1Citations
N/AReaders
Get full text
View more at Scopus

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Armitage Harper, C., Beck, K. D., Chang, E., Young, R., & Moshfeghi, D. M. (2020, October 1). Playing with fire. Ophthalmic Surgery Lasers and Imaging Retina. Slack Incorporated. https://doi.org/10.3928/23258160-20201005-01

Readers over time

‘10‘11‘12‘13‘14‘15‘16‘17‘18‘19‘20‘21‘22‘23‘2409182736

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 98

68%

Researcher 22

15%

Professor / Associate Prof. 14

10%

Lecturer / Post doc 11

8%

Readers' Discipline

Tooltip

Social Sciences 58

55%

Arts and Humanities 18

17%

Business, Management and Accounting 15

14%

Environmental Science 14

13%

Save time finding and organizing research with Mendeley

Sign up for free
0